Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: DebtBomb who wrote (55479)	4/24/2002 8:56:27 AM
From: Softechie	Read Replies (1) \| Respond to of 99280

CURE Curative Health profit rises on sales, acquisitions MINNEAPOLIS, April 24 (Reuters) - Curative Health Services, Inc. (NasdaqNM:CURE - news), a provider of biopharmaceuticals and outpatient wound care, on Wednesday reported a higher first-quarter profit, boosted by strong sales and acquisitions. Curative Health posted earnings of $2.1 million, or 19 cents per share, compared with $500,000, or 7 cents per share, a year ago. Total revenues for the first quarter jumped 68 percent to $22.8 million. The results also got a boost from the acquisitions of Hemophilia Access and Apex Therapeutic Care. Looking ahead, the company expects to post 2002 revenue of about $130 million, and revised earnings per share to between 83 cents and 85 cents per share, up from an earlier view of 80 cents. The company forecast a second-quarter profit of 21 cents per share.